Back

Efficacy and safety of edoxaban vs warfarin stratified by achieved blood pressure in 19,754 patients with hypertension in ENGAGE AF-TIMI 48

28 August 2018 (17:31 - 17:45)
Organised by:
Congress Presentation Part of: Hypertension and Atrial Fibrillation Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Sungha Park

Yonsei University, Seoul (Korea (Republic of))

3 More presentations in this session

Presentation thumbnail
Fatal attraction: hypertension and atrial fibrillation - Current knowledge
Professor A. Manolis (Athens, GR)
Slides Video
Presentation thumbnail
Long-term systolic blood pressure trajectories predict risk of incident atrial fibrillation in a general population cohort study
Doctor E. Sharashova (Tromso, NO)
Abstract Slides Video
Presentation thumbnail
Combination therapy with renin-angiotensin system inhibitors and statins is associated with reduced incidence of new-onset atrial fibrillation in hypertensive patients
Doctor T. Horio (Higashi-Osaka, JP)
Abstract

Access the full session

Session thumbnail
Hypertension and Atrial Fibrillation

The Event

Event poster

ESC Congress 2018

28 August 2018 17:31 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources